ARCHIVES

In This Issue: Congressional Testimony On NIH, NCI Appropriations, FDA Reform

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk

December 13, 2002

Immune Therapy Possible For Metastatic Breast Cancer

September 24, 2004

DCE Board Recompetition Concepts

July 17, 1987

Obituary: Rajka Medenica, controversial Physician

December 5, 1997

DeVita Losing Patience, Responds To Powers Letter

May 6, 1983